Status:
COMPLETED
Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).
Eligibility Criteria
Inclusion
- Diagnosed with cataracts
Exclusion
- Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
- \<1 diopter astigmatism by keratometry readings.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT00719732
Start Date
September 1 2007
End Date
May 1 2009
Last Update
March 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134